Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 15:18:813-823.
doi: 10.2147/TCRM.S374866. eCollection 2022.

Comparison of Diagnostic Value Between STE+LDDSE and CMR-FT for Evaluating Coronary Microvascular Obstruction in Post-PCI Patients for STEMI

Affiliations

Comparison of Diagnostic Value Between STE+LDDSE and CMR-FT for Evaluating Coronary Microvascular Obstruction in Post-PCI Patients for STEMI

Tao Liu et al. Ther Clin Risk Manag. .

Abstract

Background: Coronary microvascular obstruction (CMVO) is closely associated with poor prognosis of ST-segment elevation myocardial infarction (STEMI) patients. However, data showing the comparison between cardiac magnetic resonance feature tracking (CMR-FT) and speckle tracking echocardiography (STE) combined with low-dose dobutamine stress echocardiography (LDDSE) in evaluating CMVO was scarcely available. We aimed to explore and compare the predictive value between CMR-FT and STE+LDDSE in detecting CMVO.

Methods: Sixty-one STEMI patients were executed cardiac magnetic resonance and echocardiography within the first 5-7 days after primary percutaneous coronary intervention (PCI). The myocardial strain analysis was performed in STE, STE+LDDSE, and CMR-FT, and strain parameters included radial strain (RS), circumferential strain (CS), and longitudinal strain (LS). ROC curves were performed to predict infarcted myocardium segments with CMVO.

Results: Finally, 324 infarcted myocardium segments were analyzed, including 100 infarcted segments with CMVO and 224 segments without CMVO by the gold standard assessment of late gadolinium-enhancement cardiac magnetic resonance imaging (LGE-CMR). The results showed that CS was generally superior to RS and LS in identifying CMVO. CS in CMR-FT facilitated the detection of CMVO, with a sensitivity, specificity, and accuracy of 78.00%, 81.25%, and 80.25%, respectively. The sensitivity, specificity, and accuracy of CS in STE combined with LDDSE were better than STE alone (76.00% vs 60.00%, 79.91% vs 64.29%, and 78.70% vs 62.96%, P < 0.05). In addition, CMR-FT is not superior to STE+LDDSE for detection of CMVO (P > 0.05).

Conclusion: Low-dose dobutamine can improve the clinical value of STE for evaluating CMVO in STEMI patients. Compared with CMR-FT, STE+LDDSE might be a better choice for STEMI patients because of its safety, convenience, and low-cost.

Keywords: ST-segment elevation myocardial infarction; coronary microvascular obstruction; low-dose dobutamine; magnetic resonance feature tracking; speckle tracking echocardiography.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Typical CMVO appearance on LGE-CMR images (A) and measurement of myocardial longitudinal peak systolic strain using CMR-FT (B) and STE+LDDSE (C). Red arrow represents CMVO within infarcted myocardium segment (Ai: basis, Aii: middle, Aiii: apex), (Bi and Ci) represent longitudinal peak systolic strain measurements of CMR-FT and LDDSE, respectively. (Bii and Cii) represent longitudinal peak systolic strain–time curve of CMR-FT and LDDSE, respectively. (Biii and Ciii) represents bull’s eye plot of CMR-FT and LDDSE, respectively.
Figure 2
Figure 2
The flow chart.
Figure 3
Figure 3
The ROC curves of myocardial deformation parameters in evaluating CMVO. (AiAiii) represent ROC curves of RS, CS, and LS in STE, respectively; (BiBiii) represent ROC curves of RS, CS, and LS in STE+LDDSE, respectively; (CiCiii) represent ROC curves of RS, CS, and LS in CMR-FT, respectively.

Similar articles

Cited by

References

    1. Rios-Navarro C, Marcos-Garces V, Bayes-Genis A, Husser O, Nuñez J, Bodi V. Microvascular obstruction in ST-segment elevation myocardial infarction: looking back to move forward. J Clin Med. 2019;8:11. - PMC - PubMed
    1. Crea F. Coronary microvascular obstruction – a puzzle with many pieces. N Engl J Med. 2015;372(15):1464–1465. doi:10.1056/NEJMe1501882 - DOI - PubMed
    1. Heusch G. Myocardial ischaemia-reperfusion injury and cardioprotection in perspective. Nat Rev Cardiol. 2020;17(12):773–789. doi:10.1038/s41569-020-0403-y - DOI - PubMed
    1. Ma Q, Ma Y, Wang X, et al. Intracoronary compared with intravenous bolus tirofiban on the microvascular obstruction in patients with STEMI undergoing PCI: a cardiac MR study. Int J Cardiovasc Imaging. 2020;36(6):1121–1132. doi:10.1007/s10554-020-01800-0 - DOI - PubMed
    1. Niccoli G, Montone RA, Ibanez B, et al. Optimized treatment of ST-elevation myocardial infarction. Circ Res. 2019;125(2):245–258. doi:10.1161/CIRCRESAHA.119.315344 - DOI - PubMed